Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Aug;4(4):179-85.
doi: 10.1177/1756287212445179.

Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem

Mai Ahmed Banakhar  1 , Tariq Al-Shaiji, Magdy Hassouna
Affiliations

Sacral neuromodulation and refractory overactive bladder: an emerging tool for an old problem

Mai Ahmed Banakhar et al. Ther Adv Urol. 2012 Aug.

Abstract

Overactive bladder (OAB) syndrome negatively affects the daily life of many people. Conservative treatments, such as antimuscarinics, do not always lead to sufficient improvement of the complaints and are often associated with considerable side effects resulting in treatment failure. In the case of failure or intolerable side effects, sacral neuromodulation (SNM) and botulinum toxin intravesical injections are minimally invasive and reversible alternatives. Currently, both SNM and botulinum toxin injection have FDA approval for use in OAB patients. This mini-review attempts to provide an update on SNM as a second-line management of adults with refractory OAB, based on the available clinical evidence concerning the efficacy and safety.

Keywords: overactive bladder; sacral neuromodulation.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abrams P., Andersson K.E., Birder L., Brubaker L., Wein A., Wyndaele J.J., Khoury S. (2009) Recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse and faecal incontinence. England Health Publication Ltd, pp. 1767–1816
    1. Al-Shaiji T.F., Banakhar M., Hassouna M.M. (2011) Pelvic electrical neuromodulation for the treatment of overactive bladder symptoms. Adv Urol 2011: 757–454 - PMC - PubMed
    1. Appell R.A., Boone T.B. (2007) Surgical management of over active bladder. Curr Bladder Dysfunction Rep 2: 37–45
    1. Borawski K.M., Foster R.T., Webster G.D., Amundsen C.L. (2007) Predicting implantation with a neuromodulator using two different test stimulation techniques: A prospective randomized study in urge incontinent women. Neurourol Urodyn 26: 14–18 - PubMed
    1. Cappellano F., Bertapelle P., Spinelli M., Catanzaro F., Carone R., Zanollo A., et al. (2001) Quality of life assessment in patients who undergo sacral neuromodulation implantation for urge incontinence: an additional tool for evaluating outcome. J Urol 166: 2277–2280 - PubMed

LinkOut - more resources